Grenzach-Wyhlen, Germany

Thomas Kremer

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Thomas Kremer: Innovator in Antibody Research

Introduction

Thomas Kremer is a notable inventor based in Grenzach-Wyhlen, Germany. He has made significant contributions to the field of antibody research, particularly in the development of anti-alpha-synuclein antibodies. With a total of 5 patents to his name, Kremer's work has the potential to impact therapeutic approaches for neurodegenerative diseases.

Latest Patents

Among his latest patents, Kremer has developed anti-human alpha-synuclein antibodies and methods of using the same. This invention provides innovative solutions for targeting alpha-synuclein, a protein implicated in various neurodegenerative disorders. His work in this area is crucial for advancing medical research and treatment options.

Career Highlights

Kremer has had a distinguished career, working with prominent companies such as Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Throughout his career, Kremer has worked alongside notable colleagues, including Klaus Kaluza and Olaf Mundigl. These collaborations have enriched his research and fostered innovation in the development of therapeutic antibodies.

Conclusion

Thomas Kremer's contributions to antibody research, particularly in the area of anti-alpha-synuclein antibodies, highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical science and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…